Which is the Oldest Pharma Company in India? A Historical Deep Dive

When you walk into a pharmacy in Mumbai or Delhi today, you are surrounded by brands that seem to have been around forever. But if you ask which one actually holds the title of the oldest pharma company in India, the answer might surprise you. It isn't Sun Pharma, Cipla, or Dr. Reddy's, despite their massive global presence. The crown belongs to a name that has largely faded from public consciousness but laid the groundwork for the entire industry: Serono Laboratories.

This question often sparks debate because "pharma company" can mean different things. Are we talking about the first to manufacture antibiotics? The first to export generics? Or simply the first entity registered to produce medicines on Indian soil? To get this right, we need to look at the timeline of Indian pharmaceutical manufacturing, starting from the colonial era and moving through independence.

The Colonial Era: Before Independence

Before India became independent in 1947, the pharmaceutical landscape was dominated by foreign multinationals. Companies like Burroughs Wellcome (now part of GSK) and Glaxo had established manufacturing units in the country. However, these were extensions of British entities, not indigenous Indian companies. For decades, India relied heavily on imported finished formulations.

The turning point came in the late 1930s. In 1938, Serono Laboratories was established in Kolkata. Founded by Dr. K.N. Singh, it is widely recognized by historians and industry bodies as the first pharmaceutical manufacturing unit set up by Indians in India. Serono started with simple formulations like cough syrups and antiseptics. While it may not be a household name today, its establishment marked the beginning of local capability in drug production.

It is important to distinguish between "selling" and "manufacturing." Many older trading houses sold imported medicines, but Serono began the actual process of mixing, formulating, and packaging drugs within India. This distinction is crucial when determining who is the "oldest pharma company."

The Post-Independence Boom: 1950s and Beyond

After independence, the government pushed for self-reliance in healthcare. The Patent Act of 1970 later allowed Indian companies to reverse-engineer patented drugs, fueling the rise of the generic sector. But before that legal shift, several pioneering companies emerged in the 1940s and 1950s.

Ciba Pharmaceuticals (now Cipla) was founded in 1935 by Dr. Ghulam Mohammed Sheikh. Wait, didn't I just say Serono was first? Here is where nuance matters. Cipla started as a trading house importing chemicals and medicines in 1935. It transitioned into manufacturing later. If you define "company" as any entity involved in the pharmaceutical trade, Cipla has an earlier founding date. However, if you define it as "manufacturing," Serono’s 1938 start gives it the edge in terms of active production setup. Most industry experts accept Serono as the first manufacturer, while acknowledging Cipla as one of the earliest organized players.

Another giant, Indian Drugs & Pharmaceuticals Limited (IDPL), was established in 1956. IDPL was unique because it was set up with financial assistance from the World Bank and technical collaboration from East Germany. It played a critical role in producing essential medicines like penicillin and streptomycin during a time when supplies were scarce.

Key Legacy Players That Shaped the Industry

To understand the current landscape, you need to know who built it. Here are some of the oldest surviving pharmaceutical companies in India, listed by their founding years:

Note that while Cipla was founded in 1935, its initial focus was trading. Alkem Laboratories, founded in 1946, started as a small chemical trading business before moving into manufacturing. These timelines show how the industry evolved from importers to manufacturers.

Why Does the "Oldest" Title Matter?

You might wonder why we care about who was first. The answer lies in trust and regulatory evolution. The oldest companies navigated the early days of unregulated medicine production. They helped establish standards for quality control, Good Manufacturing Practices (GMP), and ethical marketing.

Companies like Hamdard Laboratories (founded in 1941 as a research institute, commercialized later) also hold a special place. Hamdard popularized Unani medicine alongside allopathic drugs, showing the diversity of India’s traditional healthcare systems. However, in the context of modern allopathic pharmaceutical manufacturing, Serono remains the pioneer.

The Shift to Generics and Global Exports

The real explosion of the Indian pharma industry happened after 1970. The patent law change allowed Indian firms to copy off-patent drugs from multinational companies. This created a boom in generic manufacturing.

Older companies like Cipla and Alkem adapted quickly. Newer entrants like Sun Pharma and Dr. Reddy’s leveraged this opportunity to become global leaders. Today, India is known as the "Pharmacy of the World," supplying over 50% of all generic vaccines globally and 40% of the generic medicines needed in the United States.

This success story is built on the foundation laid by those early pioneers. Without the initial infrastructure set up by Serono, IDPL, and others, the scale-up would have taken much longer.

Challenges Faced by Legacy Companies

Being old doesn’t always mean being big. Many of the oldest companies struggled to compete with the aggressive expansion of newer giants. Serono Laboratories, for instance, operates on a much smaller scale today compared to its historical significance. It focuses on niche products and regional markets.

In contrast, Cipla transformed itself into a research-driven global entity. It invested heavily in HIV/AIDS treatments, making them affordable in developing nations. This strategic pivot shows how legacy brands can reinvent themselves. The key difference is adaptability. Companies that stuck solely to their original product lines often faded, while those that embraced innovation survived.

Regulatory Landscape and Quality Standards

The oldest companies also faced the toughest regulatory hurdles. In the early days, there was little oversight. As awareness grew about substandard medicines, the Government of India introduced stricter regulations. The Drug Controller General of India (DCGI) now enforces rigorous checks.

Legacy companies had to upgrade their facilities to meet international standards like FDA approvals and WHO-GMP certification. This transition was costly and difficult. Some smaller legacy firms closed down, unable to afford the upgrades. Those that survived, like Alkem and Cipla, gained a reputation for quality that still benefits them today.

How to Verify Historical Claims

If you are researching this topic for academic or business purposes, be cautious of conflicting claims. Some companies may cite their incorporation date, while others cite their first manufacturing unit. Always check primary sources like the Ministry of Corporate Affairs records or historical archives of the Pharmacy Council of India.

Additionally, look for peer-reviewed articles in journals like the Journal of the Association of Physicians of India. These publications often provide detailed histories of medical institutions and companies, offering a more reliable account than marketing materials.

The Future of Old Brands

As the industry moves toward biologics, mRNA vaccines, and personalized medicine, what happens to the old guard? Many legacy companies are partnering with biotech startups or acquiring smaller innovators. They use their distribution networks and regulatory experience to bring new therapies to market.

For example, older companies are increasingly focusing on nutraceuticals and Ayurveda, tapping into the growing demand for holistic health solutions. This diversification helps them stay relevant in a rapidly changing market.